Esperion Therapeutics (ESPR) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.33
-0.26
-0.18
-0.11

Details

Expected EPS
-0.154767
Actual EPS
-0.21
Surprise EPS
-0.06
Surprise Percent
-35.69%

Description

⁨Esperion Therapeutics⁩ (⁦ESPR⁩) has reported earnings of ⁦-0.21⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts